Cannabinoids and the expanded endocannabinoid system in neurological disorders

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607

Gestational paracetamol exposure induces core behaviors of neurodevelopmental disorders in infant rats and modifies response to a cannabinoid agonist in females

Klein, R. M., Motomura, V. N., Debiasi, J. D., & Moreira, E. G. (2023) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2023.107279 · Cited by 14

An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry

Erridge, S., Leung, O., Holvey, C., Coomber, R., Beri, S., Khan, S. A., Weatherall, M. W., Rucker, J., Platt, M. W., & Sodergren, M. H. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12403 · Cited by 10

Interplay between the Glymphatic System and the Endocannabinoid System: Implications for Brain Health and Disease

Osuna‐Ramos, J. F., Camberos-Barraza, J., Torres-Mondragón, L. E., Rábago-Monzón, Á. R., Camacho-Zamora, A., Valdez-Flores, M. A., Angulo‐Rojo, C., Guadrón‐Llanos, A. M., Picos-Cárdenas, V. J., Calderón-Zamora, L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417458 · Cited by 13

Heteromers Formed by GPR55 and Either Cannabinoid CB1 or CB2 Receptors Are Upregulated in the Prefrontal Cortex of Multiple Sclerosis Patients

Menéndez-Pérez, C., Rivas‐Santisteban, R., del Valle, E., Tolivia, J., Navarro, A., Franco, R., & Martínez‐Pinilla, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084176 · Cited by 11

Confound, Cause, or Cure: The Effect of Cannabinoids on HIV-Associated Neurological Sequelae

Starr, A., Jordan‐Sciutto, K. L., & Mironets, E. (2021) · Viruses · doi:10.3390/v13071242 · Cited by 10

The Endocannabinoid System in Caenorhabditis elegans

Estrada-Valencia, R., de Lima, M. E., Colonnello, A., Rangel‐López, E., Saraiva, N. R., Ávila, D. S., Aschner, M., & Santamarı́a, A. (2021) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2021_64 · Cited by 10

Successful and Unsuccessful Brain Aging in Pets: Pathophysiological Mechanisms behind Clinical Signs and Potential Benefits from Palmitoylethanolamide Nutritional Intervention

Scuderi, C., & Golini, L. (2021) · Animals · doi:10.3390/ani11092584 · Cited by 14

ALPACA: A machine Learning Platform for Affinity and selectivity profiling of CAnnabinoids receptors modulators

Delre, P., Contino, M., Alberga, D., Saviano, M., Corriero, N., & Mangiatordi, G. F. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107314 · Cited by 9

Patent review of cannabinoid receptor type 2 (CB 2 R) modulators (2016-present)

Kosar, M., Mach, L., Carreira, E. M., Nazaré, M., Pacher, P., & Grether, U. (2024) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2024.2368745 · Cited by 10

Dissecting the role of cannabinoids in vascular health and disease

Guo, Y., Wei, X., Pei, J., Yang, H., & Zheng, X. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31373 · Cited by 10

JWH133 attenuates behavior deficits and iron accumulation in 6-OHDA-induced Parkinson’s disease model rats

Liu, M., Pan, D., Wang, M., Deng, H., & Ma, Z. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00137.2024 · Cited by 9

From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling

Briand‐Mésange, F., Gennero, I., Salles, J., Trudel, S., Dahan, L., Ausseil, J., Payrastre, B., Salles, J., & Chap, H. (2024) · Molecules · doi:10.3390/molecules29153694 · Cited by 10

Enhanced visualization of endocannabinoids spatial distribution in mouse brain via MALDI-2 mass spectrometry imaging

Salviati, E., Guida, F., Gioia, D. L., Merciai, F., Maione, S., Marzo, V. D., Campiglia, P., Piscitelli, F., & Sommella, E. (2025) · Talanta · doi:10.1016/j.talanta.2025.127811 · Cited by 9

A Holistic Review of Cannabis and Its Potential Risks and Benefits in Mental Health

Borrego-Ruiz, A., & Borrego, J. J. (2025) · Psychiatry International · doi:10.3390/psychiatryint6030092 · Cited by 13

The Role of the Possible Receptors and Intracellular Pathways in Protective Effect of Exogenous Anandamide in Kindling Model of Epilepsy

Khaksar, S., Salimi, M., Zeinoddini, H., & Naderi, N. (2022) · Neurochemical Research · doi:10.1007/s11064-021-03517-5 · Cited by 9

Cannabidiol Promotes Neuronal Differentiation Using Akt and Erk Pathways Triggered by Cb1 Signaling

Blando, S., Raffaele, I., Chiricosta, L., Valeri, A., Gugliandolo, A., Silvestro, S., Pollastro, F., & Mazzon, E. (2022) · Molecules · doi:10.3390/molecules27175644 · Cited by 10

The TRPV1 Receptor Is Up-Regulated by Sphingosine 1-Phosphate and Is Implicated in the Anandamide-Dependent Regulation of Mitochondrial Activity in C2C12 Myoblasts

Standoli, S., Pecchioli, S., Tortolani, D., Meo, C. D., Fanti, F., Sergi, M., Bacci, M., Seidita, I., Bernacchioni, C., Donati, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911103 · Cited by 9

Shared Genetic Regulatory Networks Contribute to Neuropathic and Inflammatory Pain: Multi-Omics Systems Analysis

Ye, F., Du, L., Huang, W., & Wang, S. (2022) · Biomolecules · doi:10.3390/biom12101454 · Cited by 9

Clinical Research Evidence Supporting Administration and Dosing Recommendations of Medicinal Cannabis as Analgesic in Cancer Patients

Christensen, C., Allesø, M., Rose, M., & Cornett, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010307 · Cited by 10

Deciphering Complex Interactions in Bioactive Lipid Signaling

Maccarrone, M. (2023) · Molecules · doi:10.3390/molecules28062622 · Cited by 10

The Influence of Cannabinoids on Drosophila Behaviors, Longevity, and Traumatic Injury Responses of the Adult Nervous System

Candib, A., Lee, N., Sam, N., Cho, E., Rojas, J. J., Hastings, R., DeAlva, K., Khon, D., González, A., Molina, B., et al. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0285 · Cited by 12

Novel topical anandamide formulation for alleviating peripheral neuropathic pain

Police, A., Shankar, V. K., Pandey, P., Rangappa, S., Doerksen, R. J., & Murthy, S. N. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123085 · Cited by 9

The FAAH inhibitor URB597 reduces cocaine intake during conditioned punishment and mitigates cocaine seeking during withdrawal

Alegre-Zurano, L., García-Baos, A., Castro‐Zavala, A., Medrano, M., Gallego‐Landin, I., & Valverde, O. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115194 · Cited by 9

Quantal size increase induced by the endocannabinoid 2‐arachidonoylglycerol requires activation of CGRP receptors in mouse motor synapses

Tarasova, E., Bogacheva, P. O., Chernyshev, K., & Balezina, O. P. (2023) · Synapse · doi:10.1002/syn.22281 · Cited by 9

Cannabidiol and epilepsy

Moreira, F. A., de Oliveira, A. C. P., Santos, V. R., & Moraes, M. F. D. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.03.009 · Cited by 9

Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention

Soldevila‐Domenech, N., Fagundo, A. B., Cuenca‐Royo, A., Forcano, L., Gomis‐González, M., Boronat, A., Pastor, A., Castañer, O., Zomeño, M. D., Goday, A., et al. (2024) · Nutrition Journal · doi:10.1186/s12937-024-00966-w · Cited by 12

Cannabidiol induces autophagy via CB1 receptor and reduces α-synuclein cytosolic levels

Erustes, A. G., Abílio, V. C., Bincoletto, C., Piacentini, M., Pereira, G. J. S., & Smaili, S. S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149414 · Cited by 10

Sapropterin (BH4) Aggravates Autoimmune Encephalomyelitis in Mice

Schmitz, K., Trautmann, S., Hahnefeld, L., Fischer, C., Schreiber, Y., Wilken‐Schmitz, A., Gurke, R., Brunkhorst, R., Werner, E. R., Watschinger, K., et al. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01043-4 · Cited by 9

Alpha/Beta-Hydrolase Domain-Containing 6: Signaling and Function in the Central Nervous System

Zhang, H., Li, X., Liao, D., Luo, P., & Jiang, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.784202 · Cited by 10

Potential therapeutic targets for the treatment of opioid abuse and pain

Kiguchi, N., & Ko, M. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.09.002 · Cited by 9

Why Multitarget Vasodilatory (Endo)cannabinoids Are Not Effective as Antihypertensive Compounds after Chronic Administration: Comparison of Their Effects on Systemic and Pulmonary Hypertension

Remiszewski, P., & Malinowska, B. (2022) · Pharmaceuticals · doi:10.3390/ph15091119 · Cited by 9

Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome

Soldevila‐Domenech, N., Pastor, A., Sala‐Vila, A., Lázaro, I., Boronat, A., Muñoz, D., Castañer, O., Fagundo, A. B., Corella, D., Fernández‐Aranda, F., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1076677 · Cited by 9

The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol

de Oliveira, B. S. A., Milanezi, D. S., Gonzaga, P. D. V., Detoni, F. R., & Soriano, R. N. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12172 · Cited by 10

Therapeutic potential of CBD in Autism Spectrum Disorder

Pedrazzi, J. F. C., Hassib, L., Ferreira, F. R., Hallak, J. E. C., Del-Bel, E., & Crippa, J. A. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.05.002 · Cited by 12

Caloric restriction, physical exercise, and CB1 receptor blockade as an efficient combined strategy for bodyweight control and cardiometabolic status improvement in male rats

Trinidad, L. L., Martínez, R., Kapravelou, G., Galisteo, M., Aranda, P., Porres, J. M., & López‐Jurado, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-83709-9 · Cited by 9

Early Consumption of Cannabinoids: From Adult Neurogenesis to Behavior

Netzahualcoyotzi, C., Rodríguez–Serrano, L. M., Chávez–Hernández, M. E., & Buenrostro-Jáuregui, M. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147450 · Cited by 9

The metabotropic glutamate receptor 5 as a biomarker for psychiatric disorders

(2023) · International Review of Neurobiology · doi:10.1016/bs.irn.2022.10.007 · Cited by 8

Interactions Between the Ubiquitin–Proteasome System, Nrf2, and the Cannabinoidome as Protective Strategies to Combat Neurodegeneration: Review on Experimental Evidence

Monsalvo-Maraver, L. Á., Ovalle-Noguez, E. A., Nava-Osorio, J., Maya-López, M., Rangel‐López, E., Túnez, I., Tinkov, A. A., Tizabi, Y., Aschner, M., Santamarı́a, A., et al. (2024) · Neurotoxicity Research · doi:10.1007/s12640-024-00694-3 · Cited by 9

Interplay between endocannabinoids and dopamine in the basal ganglia: implications for pain in Parkinson’s disease

Mancini, M., Calculli, A., Martino, D. D., & Pisani, A. (2024) · Journal of Anesthesia Analgesia and Critical Care · doi:10.1186/s44158-024-00169-z · Cited by 8

Cannabinoids’ Role in Modulating Central and Peripheral Immunity in Neurodegenerative Diseases

Sharon, N., Yarmolinsky, L., Khalfin, B., Fleisher‐Berkovich, S., & Ben‐Shabat, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126402 · Cited by 9

Phospholipase C beta 1 in the dentate gyrus gates fear memory formation through regulation of neuronal excitability

Lee, J., Jeong, Y., Park, S., Kim, S., Oh, H., Jin, J., Sohn, J., Kim, D., Shin, H., & Heo, W. D. (2024) · Science Advances · doi:10.1126/sciadv.adj4433 · Cited by 8

The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products

Russo, E., Agredano, P. M., Flachenecker, P., Lawthom, C., Munro, D., Hindocha, C., Bagul, M., & Trinka, E. (2024) · Journal of Cannabis Research · doi:10.1186/s42238-024-00242-y · Cited by 8

The analgesic mechanism of electroacupuncture at the central level for neuropathic pain: a review of studies based on animal experiments

Qi, P., Li, Q., Han, M., Cui, Y., Zhou, X., Sun, Z., Ding, S., Yu, M., Zhang, H., & Yin, H. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1587471 · Cited by 10

Agathadiol, a labdane diterpenoid from juniper berries, is a positive allosteric modulator of CB1R

Salamone, S., Appendino, G., Khalili, A., Pollastro, F., Muñóz, E., & Unciti-Broceta, J. D. (2021) · Fitoterapia · doi:10.1016/j.fitote.2021.105059 · Cited by 8

Aβ Chronic Exposure Promotes an Activation State of Microglia through Endocannabinoid Signalling Imbalance

Scipioni, L., Tortolani, D., Ciaramellano, F., Fanti, F., Gazzi, T., Sergi, M., Nazaré, M., Oddi, S., & Maccarrone, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076684 · Cited by 8

Cannabidiol Compared to Pharmacological Treatment as Usual for Crack Use Disorder: A Feasibility, Preliminary Efficacy, Parallel, Double-Blind, Randomized Clinical Trial

Gallassi, A. D., de Oliveira, A. W. C., Rodrigues, L. A., Nakano, E. Y., Ruas, P. A. S., Mata, J. A. I. D. L., Júnior, E. F., Gomes, J. D. A., Caroba, M. E. S., Silva, M., et al. (2024) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-024-01287-z · Cited by 10

The Bidirectional Interplay Between Substances of Abuse and Gut Microbiome Homeostasis

Borrego-Ruiz, A., & Borrego, J. J. (2025) · Life · doi:10.3390/life15060834 · Cited by 12

Endocannabinoids and related lipids in serum from patients with amyotrophic lateral sclerosis

Carter, G. T., McLaughlin, R. J., Cuttler, C., Sauber, G., Weeks, D. L., Hillard, C. J., & Weiss, M. D. (2020) · Muscle & Nerve · doi:10.1002/mus.27096 · Cited by 8

A New Ultrasensitive Bioluminescence-Based Method for Assaying Monoacylglycerol Lipase

Miceli, M., Casati, S., Allevi, P., Berra, S., Ottria, R., Rota, P., Branchini, B. R., & Ciuffreda, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116148 · Cited by 8

Interplay Between Endocannabinoid System and Neurodegeneration: Focus on Polypharmacology

Seghetti, F., Gobbi, S., Belluti, F., Rampa, A., & Bisi, A. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666211115124639 · Cited by 8

Improved cyclobutyl nabilone analogs as potent CB1 receptor agonists

Papanastasiou, I. P., Georgiadis, M., Iliopoulos‐Tsoutsouvas, C., Paronis, C. A., Brust, C. A., Tran, N. K., Ji, L., Ma, X., Wood, J. T., Zvonok, N., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114027 · Cited by 8

Synthesis of Fatty Acid Bioconjugates and Related Derivatives

Crauste, C., Galano, J., Guy, A., Lehoux, J., Durand, T., & Balas, L. (2022) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202101502 · Cited by 8

Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies

Vimal, D., D’Souza, L. C., Rai, V., Lal, S., Sharma, A., & Gupta, S. C. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220525124818 · Cited by 8

Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy

Parameswaran, J., Goicoechea, L., Planas‐Serra, L., Pastor, A., Ruíz, M., Calingasan, N. Y., Guilera, C., Aso, E., Boada, J., Pamplona, R., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02451-2 · Cited by 9

Cannabis Use and CKD: Epidemiological Associations and Mendelian Randomization

Dellepiane, S., Paranjpe, I., Rajagopal, M., Kamat, S., O’Hagan, R., Gulamali, F. F., Rein, J. L., Charney, A. W., Do, R., Coca, S. G., et al. (2022) · Kidney Medicine · doi:10.1016/j.xkme.2022.100582 · Cited by 9

Contextual fear expression engages a complex set of interactions between ventromedial prefrontal cortex cholinergic, glutamatergic, nitrergic and cannabinergic signaling

Uliana, D. L., Diniz, C. R. A. F., da Silva, L. A., Borges‐Assis, A. B., Lisboa, S. F. D. S., & Resstel, L. B. M. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109538 · Cited by 8

DAGLβ is the principal synthesizing enzyme of 2-AG and promotes aggressive phenotype of intrahepatic cholangiocarcinoma via AP-1/DAGLβ/miR4516 feedforward circuitry

Ma, M., Zeng, G., Tan, B., Zhao, G., Su, Q., Zhang, W., Song, Y., Liang, J., Xu, B., Wang, Z., et al. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00243.2022 · Cited by 8

Exploring potential anti-inflammatory effects of medicinal cannabis

Gurgenci, T., Kijanka, G. S., Greer, R. M., Huggett, G., Good, P. D., Moniruzzaman, M., & Hardy, J. R. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-08069-8 · Cited by 8

Novel pyrrole based CB2 agonists: New insights on CB2 receptor role in regulating neurotransmitters' tone

Micco, S. D., Ciaglia, T., Salviati, E., Michela, P., Kostrzewa, M., Musella, S., Moriello, A. S., Sarno, V. D., Smaldone, G., Matteo, F. D., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116298 · Cited by 8

Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice

Gonzalo‐Consuegra, C., Santos‐García, I., García‐Toscano, L., Martín-Baquero, R., Rodríguez‐Cueto, C., Wittwer, M., Dżygiel, P., Grether, U., de Lago, E., & Fernández‐Ruíz, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116473 · Cited by 8

Monitoring Cannabinoid CB2 -Receptor Mediated cAMP Dynamics by FRET-Based Live Cell Imaging

Mensching, L., Rading, S., Nikolaev, V. O., & Karsak, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217880 · Cited by 8

A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation

League, A. F., Yadav-Samudrala, B. J., Kolagani, R., Cline, C. A., Jacobs, I. R., Manke, J., Niphakis, M. J., Cravatt, B. F., Lichtman, A. H., Ignatowska-Jankowska, B. M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1374301 · Cited by 7

The CB2 Receptor in Immune Regulation and Disease: Genetic Architecture, Epigenetic Control, and Emerging Therapeutic Strategies

Kalkan, H., & Flamand, N. (2025) · DNA · doi:10.3390/dna5040059 · Cited by 7

Therapeutic Potential for Cannabidiol on Alzheimer’s Disease-Related Neuroinflammation: A Systematic Review and Meta-Analysis

Wu, S., Rajiah, T., & Ali, A. B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411963 · Cited by 9

Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives

Ben‐Shabat, S., Yarmolinsky, L., Sharon, N., Zeadnaa-Aldda, T., Dayan, S., Khalfin, B., & Fleisher‐Berkovich, S. (2026) · Biomolecules · doi:10.3390/biom16020225 · Cited by 7

Endocannabinoid system as a therapeutic target for psychostimulants relapse: A systematic review of preclinical studies

Karimi‐Haghighi, S., Mahmoudi, M., Sayehmiri, F., Mozafari, R., & Haghparast, A. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175669 · Cited by 7

Endocannabinoid system and aggression across animal species

Migliaro, M., Ruiz‐Contreras, A. E., Herrera-Solís, A., Méndez‐Díaz, M., & Prospero-Garcia, O. E. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105375 · Cited by 8

Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19—A Scoping Review

Scott, C., Hall, S., Zhou, J., & Lehmann, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010227 · Cited by 7

Anandamide-Mediated Modulation of Nociceptive Transmission at the Spinal Cord Level

Spicarova, D., & Paleček, J. (2024) · Physiological Research · doi:10.33549/physiolres.935371 · Cited by 7

Toward the identification of a phytocannabinoid-like compound in the flowers of a South African medicinal plant (Leonotis leonurus)

Hunter, E., Stander, M. A., Koßmann, J., Chakraborty, S., Prince, S., Peters, S. W., & Loedolff, B. (2020) · BMC Research Notes · doi:10.1186/s13104-020-05372-z · Cited by 7

Between Science and Big Business: Tapping Mary Jane’s Uncharted Potential

Grotsch, K., & Fokin, V. V. (2022) · ACS Central Science · doi:10.1021/acscentsci.1c01100 · Cited by 7

The Role of Cannabinoids in CNS Development: Focus on Proliferation and Cell Death

Bockmann, E. C., Brito, R., Madeira, L. F., Sampaio, L. D. S., Reis, R. A. D. M., França, G. R., & Calaza, K. D. C. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01263-y · Cited by 8

Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB1 receptor density in cell membranes: an alternative to radioligand binding methods

Saumell-Esnaola, M., Elejaga-Jimeno, A., Echeazarra, L., Roman, L. B., Barrondo, S., de Jesús, M. L., González‐Burguera, I., Gómez‐Caballero, A., Goicolea, M. A., Sallés, J., et al. (2022) · Microbial Cell Factories · doi:10.1186/s12934-022-01914-1 · Cited by 7

Cannabidiol Protects Striatal Neurons by Attenuating Endoplasmic Reticulum Stress

Patel, V., Abu-Hijleh, F. A., Rigg, N., & Mishra, R. K. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0090 · Cited by 7

Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition

Morgillo, C. M., Lupia, A., Deplano, A., Pirone, L., Fiorillo, B., Pedone, E. M., Luque, F. J., Onnis, V., Moraca, F., & Catalanotti, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415502 · Cited by 7

In silico analyses of the involvement of GPR55, CB1R and TRPV1: response to THC, contribution to temporal lobe epilepsy, structural modeling and updated evolution

Cherry, A. L., Wheeler, M. J., Mathisova, K., & Miceli, M. D. (2024) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2024.1294939 · Cited by 7

Divergent Effects of Systemic and Intracollicular CB Receptor Activation Against Forebrain and Hindbrain-Evoked Seizures in Rats

Santos, V. R., Hammack, R. J., Wicker, E., N’Gouemo, P., & Forcelli, P. A. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.595315 · Cited by 7

ToxPoint: Toxicology Studies on Δ9-tetrahydrocannabinol and Cannabidiol-containing Products Available to Consumers Are Lacking

Bobst, S., Ryan, K., Plunkett, L. M., & Willett, K. L. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa135 · Cited by 7

Neuroprotective and neurotoxic effects of endocannabinoid-like compounds, N-arachidonoyl dopamine and N-docosahexaenoyl dopamine in differentiated cultures of induced pluripotent stem cells derived from patients with Parkinson’s disease

Novosadova, E. V., Antonov, S. A., Arsenyeva, E. L., Kobylanskiy, A., Vanyushina, Y., Malova, T., Хаспеков, Л. Г., Bobrov, М. Y., Безуглов, В. В., Tarantul, V. Z., et al. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.11.010 · Cited by 7

Cannabinoid-2 Receptor Activation Attenuates Sulfur Mustard Analog 2-Chloroethyl-Ethyl-Sulfide-Induced Acute Lung Injury in Mice

Nicholson, G., Richards, N., Lockett, J., Ly, M., Nair, R. V., Kim, W., Vinod, K. Y., & Nagre, N. N. (2025) · Pharmaceuticals · doi:10.3390/ph18020236 · Cited by 6

The cannabinoid receptor 1 mediates exercise-induced improvements of motor skill learning and performance in parkinsonian mouse

Zikereya, T., Liu, C., Wei, L., Wang, Y., Zhang, Z., Han, C., Shi, K., & Chen, W. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115289 · Cited by 6

Chemoproteomics identifies protein ligands for monoacylglycerol lipids

Shanbhag, K., Mhetre, A. B., Saharan, O., Devarajan, A., Rai, A., Madhusudhan, M. S., Chakrapani, H., & Kamat, S. S. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01589-w · Cited by 6

Neurotransmitter Regulatory Networks: A New Perspective on Cancer Therapy

Zhang, X., Cao, J., Zhang, Y., Li, C., & Jing, Y. (2025) · Biomolecules · doi:10.3390/biom15101429 · Cited by 8

Therapeutic uses of Cannabis sativa L. Current state and future perspectives

Fraguas‐Sánchez, A. I., & Torres‐Suárez, A. I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89867-6.00010-x · Cited by 6

Resident Astrocytes can Limit Injury to Developing Hippocampal Neurons upon THC Exposure

Krassnitzer, M., Boisvert, B., Beiersdorf, J., Harkany, T., & Keimpema, E. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03836-1 · Cited by 6

Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors

Paredes-Ruiz, K. J., Chavira-Ramos, K., Galván‐Arzate, S., Rangel‐López, E., Karasu, Ç., Túnez, I., Skalny, A. V., Ke, T., Aschner, M., Orozco‐Morales, M., et al. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00661-4 · Cited by 6

Could cannabinoids provide a new hope for ovarian cancer patients?

Kaur, R., & Javid, F. A. (2023) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1122 · Cited by 6

Sex-Dependent Altered Expression of Cannabinoid Signaling in Hippocampal Astrocytes of the Triple Transgenic Mouse Model of Alzheimer’s Disease: Implications for Controlling Astroglial Activity

Pacheco-Sánchez, B., Tovar, R., Rabaa, M. B., Salido, L. S., Vargas, A., Suárez, J., de Fonseca, F. R., & Rivera, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612598 · Cited by 6

Sperm proteostasis: Can-nabinoids be chaperone's partners?

Montero, K. J. F., Frontini-López, Y. R., Fontecilla-Escobar, J., & Ruete, M. C. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122167 · Cited by 6

Association of cannabis use with patient-reported pain measures among adults with chronic pain in US states with medical cannabis programs

Bicket, M. C., Stone, E. M., & McGinty, E. B. (2023) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2023-104833 · Cited by 6

Implementation and validation of a UHPLC-MS/MS method for quantification of the endocannabinoids AEA and 2-AG in cerebral interstitial fluid and plasma

Weiermair, T., Švehlíková, E., Magnes, C., Boulgaropoulos, B., Altendorfer‐Kroath, T., Hummer, J., & Eberl, A. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115844 · Cited by 7

Xanthine or hypoxanthine or both may play therapeutical effect in Parkinson's disease through the endocannabinoid system

Chang, B., Niu, C., & Jiang, Y. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111231 · Cited by 6

Characterization of Hair Metabolome in 5xFAD Mice and Patients with Alzheimer’s Disease Using Mass Spectrometry-Based Metabolomics

Chang, C., Hsu, J.-Y., Lo, Y., Liu, Y., Mee-inta, O., Lee, H., Kuo, Y., & Liao, P. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00587 · Cited by 6

The Fetal Alcohol Spectrum Disorders—An Overview of Experimental Models, Therapeutic Strategies, and Future Research Directions

Król, M., Skowron, P., Skowron, K. P., & Gil, K. (2024) · Children · doi:10.3390/children11050531 · Cited by 6

Maternal obesity induces sex-specific changes in the endocannabinoid system of the hypothalamus and dorsal hippocampus of offspring associated with anxiety-like behavior in adolescent female rats

Calviño, C., de Almeida, M. M., Reis-Gomes, C. F., Andrade, B. D. S., Neves, G. A., Pazos-Moura, C. C., & Trevenzoli, I. H. (2024) · Hormones and Behavior · doi:10.1016/j.yhbeh.2024.105648 · Cited by 6

Exploring Endocannabinoid System: Unveiling New Roles in Modulating ER Stress

Capolupo, I., Miranda, M. R., Musella, S., Sarno, V. D., Manfra, M., Ostacolo, C., Bertamino, A., Campiglia, P., & Ciaglia, T. (2024) · Antioxidants · doi:10.3390/antiox13111284 · Cited by 6

FAAH Inhibition Counteracts Neuroinflammation via Autophagy Recovery in AD Models

Armeli, F., Coccurello, R., Giacovazzo, G., Mengoni, B., Paoletti, I., Oddi, S., Maccarrone, M., & Businaro, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212044 · Cited by 6

ABHD6 loss-of-function in mesoaccumbens postsynaptic but not presynaptic neurons prevents diet-induced obesity in male mice

Lau, D., Tobin, S. W., Pribiag, H., Nakajima, S., Fisette, A., Matthys, D., Franco-Flores, A. K., Peyot, M., Madiraju, S. R. M., Prentki, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54819-5 · Cited by 7

Extrachromosomal expression of functional Cannabis sativa cannabidiolic acid synthase in Phaedodactylum tricornutum

Fantino, E. I., Messaabi, A., Mérindol, N., Awwad, F., Sene, N., Gélinas, S., Custeau, A., Rhéaume, K.-L., Meddeb‐Mouelhi, F., & Desgagné‐Penix, I. (2024) · Algal Research · doi:10.1016/j.algal.2024.103889 · Cited by 7

Investigating the role of a novel hemizygous FAAH2 variant in neurological and metabolic disorders

Vinci, M., Greco, D., Treccarichi, S., Musumeci, A., Gloria, A., Federico, C., Saccone, S., Calı̀, F., & Sirrs, S. M. (2025) · Gene · doi:10.1016/j.gene.2025.149703 · Cited by 6

Endocannabinoidome and its role in neurological disorders-A comprehensive update of existing literature

Dutta, R. (2021) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001049 · Cited by 1

Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders

Estrada, J. A., & Contreras, I. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200217140255 · Cited by 33

Discovery of the Endocannabinoid System: A Breakthrough in Neuroscience

Hassanzadeh, P. (2014) · Archives of Neuroscience · doi:10.5812/archneurosci.15030 · Cited by 3

Endocannabinoids Part II: pathological CNS conditions involving the endocannabinoid system and their possible treatment with endocannabinoid-based drugs

Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2001) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.5.3.349 · Cited by 4

Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies

Duncan, R. S., Riordan, S. M., Gernon, M. C., & Koulen, P. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382220 · Cited by 30